Efficacy and Safety of Apatinib plus Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cancer: A Phase II Trial

Table 1

Baseline characteristics.

Variable	Patients ()
Sex, (%)
Male	29 (74.4)
Female	10 (25.6)
Age (years), (%)
>60	27 (69.3)
≤60	12 (30.7)
ECOG performance status, (%)
0	29 (74.4)
1	10 (25.6)
Primary tumor location, (%)
Upper	8 (20.5)
Middle	30 (76.9)
Lower	1 (2.6)
cT stage
T3	26
T4a	13
cN stage
N1	21
N2	16
N3	2
cTNM stage, (%)
IIIb	36 (92.4)
IVa	3 (7.6)
Hypertension, (%)
Yes	7 (17.9)
No	32 (82.1)
Smoking, (%)
Yes	10 (25.6)
No	29 (74.7)
Drinking, (%)
Yes	22 (56.4)
No	17 (43.6)